Proposed Law Aims to Restrict Antibiotic Use on Farms

A measure moving through the California legislature requires farmers to obtain a prescription to administer antibiotics to livestock.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, MACIEKLEWCalifornia lawmakers this week (August 11) approved a bill restricting the use of antibiotics in farm animals to cases substantiated by prescriptions and requiring that drugmakers label antibiotics as prescription-only. Although federal guidelines request similar practices, if enacted, this would be the first instance of such restrictions becoming law.

The rule is intended to curb the practice of using antibiotics to beef up livestock, a tactic that has been fingered as augmenting antibiotic-resistance in humans. Yet, environmental advocates are disappointed.

The bill “would prohibit drug manufacturers from selling antibiotics for ‘growth promotion’ uses, but would allow the very same drugs to be used routinely to help animals survive unhealthy living conditions,” Jonathan Kaplan, the director of the National Resources Defense Council’s Food and Agriculture program, wrote on his staff’s blog. “It’s a gigantic loophole that we fear will do little to change actual drug use.”

The bill’s author, Senator Jerry Hill (D-San Mateo), responded to critics in July, writing in the Sacramento Bee that “preventative use can be judicious. . . Just as humans ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies